BiOptix Diagnostics Obtains $663,300 New Funding

  • Feed Type
  • Date
  • Company Name
    BiOptix Diagnostics
  • Mailing Address
    1775 38th St. Boulder, CO 80301 USA
  • Company Description
    The company’s mission is to develop its proprietary E-SPR (Enhanced Surface Plasmon Resonance) technology platform for the detection of molecular interactions.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 18 investors participated in the offering as amended. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy